doi:10.11852/zgetbjzz2014-22-09-15

Abstract

摘要： 抽动障碍(tic disorder,TD)是儿童常见的神经心理疾病,常常合并其他精神心理疾病如注意力缺陷多动症(attention deficit hyperactivity disorder,ADHD)等。TD和ADHD的病理生理机制可能都涉及到多巴胺(dopamine,DA)这一重要的神经递质,但目前关于两种疾病的DA功能的假设在TD合并ADHD时出现相互矛盾。本文从TD合并ADHD的流行病学、DA相关机制及治疗方面进行综述,以期为解释这一矛盾现象提供线索,为临床药物治疗提供参考。

关键词: 抽动障碍, 注意力缺陷多动症, 多巴胺, 药物治疗

CLC Number:

R749.94

向上, 肖农. 抽动障碍合并注意力缺陷多动症的多巴胺相关假设与治疗[J]. 中国儿童保健杂志, 2014, 22(9): 946-948.

0
/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/10.11852/zgetbjzz2014-22-09-15

https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/Y2014/V22/I9/946

References

[1] Kurlan R.Tourette's syndrome[J].New England Journal of Medicine,2010,363(24):2332-2338.
[2] Knight T,Steeves T,Day L,et al.Prevalence of tic disorders:a systematic review and meta-analysis[J].Pediatric neurology,2012,47(2):77-90.
[3] Polanczyk G,de Lima M,Horta B,et al.The worldwide prevalence of ADHD:a systematic review and metaregression analysis[J].American journal of psychiatry,2007,164(6):942-948.
[4] Khalifa N,Von Knorring AL.Psychopathology in a Swedish population of school children with tic disorders[J].Journal of the AmericanAcademy of Child & Adolescent Psychiatry,2006,45(11):1346-1353.
[5] Scharf JM,Miller LL,Mathews CA,et al.Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort[J].Journal of the American Academy of Child & Adolescent Psychiatry,2012,51(2):192-201.
[6] Sukhodolsky DG,Scahill L,Zhang H,et al.Disruptive behavior in children with Tourette's syndrome:association with ADHD comorbidity,tic severity,and functional impairment[J].Journal of the American Academy of Child & Adolescent Psychiatry,2003,42(1):98-105.
[7] Debes NMM,Hjalgrim H,Skov L.The presence of attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder worsen psychosocial and educational problems in Tourette syndrome[J].Journal of Child Neurology,2010,25(2):171-181.
[8] Eddy CM,Rizzo R,Gulisano M,et al.Quality of life in young people with Tourette syndrome:a controlled study[J].Journal of Neurology,2011,258(2):291-301.
[9] Eddy CM,Rizzo R,Cavanna A E.Neuropsychological aspects of Tourette syndrome:a review[J].Journal of Psychosomatic Research,2009,67(6):503-513.
[10] Roessner V,Walitza S,Riederer F,et al.Tetrahydroisoquinoline derivatives:a new perspective on monoaminergic dysfunction in children with ADHD?[J].Behavioral and Brain Functions,2007,3(1):1-6.
[11] Shaw M,Hodgkins P,Caci H,et al.A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder:effects of treatment and non-treatment[J].BMC Medicine,2011,10(1):99-99.
[12] Volkow ND,Wang GJ,Newcorn J,et al.Brain dopamine transporter levels in treatment and drug naive adults with ADHD[J].Neuroimage,2007,34(3):1182-1190.
[13] Bloch MH,Panza KE,Landeros-Weisenberger A,et al.Meta-analysis:treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders[J].Journal of the American Academy of Child & Adolescent Psychiatry,2009,48(9):884-893.
[14] Gadow KD,Sverd J,Nolan EE,et al.Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder[J].Journal of the American Academy of Child & Adolescent Psychiatry,2007,46(7):840-848.
[15] Gaffney GR,Perry PJ,Lund BC,et al.Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome[J].Journal of the American Academy of Child & Adolescent Psychiatry,2002,41(3):330-336.
[16] Kollins SH,Jain R,Brams M,et al.Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD[J].Pediatrics,2011,127(6):e1406-e1413.
[17] Allen AJ,Kurlan RM,Gilbert DL,et al.Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders[J].Neurology,2005,65(12):1941-1949.
[18] Spencer TJ,Sallee FR,Gilbert DL,et al.Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome[J].Journal of Attention Disorders,2008,11(4):470-481.
[19] Singer HS,Brown J,Quaskey S,et al.The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome:a double-blind placebo-controlled study with clonidine and desipramine[J].Pediatrics,1995,95(1):74-81.
[20] Spencer T,Biederman J,Coffey B,et al.A double-blind comparison of desipramine and placebo in cChildren and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder[J].Archives of General Psychiatry,2002,59(7):649-656.
[21] Wenzel C,Kleimann A,Bokemeyer S,et al.Aripiprazole for the treatment of Tourette syndrome:A case series of 100 patients[J].Journal of Clinical Psychopharmacology,2012,32(4):548-550.
[22] Masi G,Gagliano A,Siracusano R,et al.Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder:a 12-week,open-label,preliminary study[J].Journal of Child and Adolescent Psychopharmacology,2012,22(2):120-125.

抽动障碍合并注意力缺陷多动症的多巴胺相关假设与治疗

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Rong, LI Nian, WU Dandan, HUANG Rong, CHEN Yinhua. Effect of methylphenidate hydrochloride prolonged-release tablets on the growth of children with attention deficit hyperactivity disorder [J]. Chinese Journal of Child Health Care, 2023, 31(7): 731-735.
[2]	ZHANG Chao. Application of early start Denver model in the rehabilitation of children with autism spectrum disorder of different conditions [J]. Chinese Journal of Child Health Care, 2023, 31(7): 736-740.
[3]	LI Xiuhong. Early identification of Chinese developmental dyslexia should be valued [J]. Chinese Journal of Child Health Care, 2023, 31(6): 586-589.
[4]	CAO Aihua. Early screening, diagnosis and intervention of learning disabilities in children [J]. Chinese Journal of Child Health Care, 2023, 31(6): 590-594.
[5]	WANG Hongan, YU Dongchuan, LIU Fulin, CHI Xia. Feasibility study on rapid screening of learning disabilities by number cancellation test in combination with machine learning algorithm [J]. Chinese Journal of Child Health Care, 2023, 31(6): 595-600.
[6]	WANG Jingrong, MA Xiquan, JIN Zhijuan. Research progress in childhood narcissism [J]. Chinese Journal of Child Health Care, 2023, 31(6): 634-639.
[7]	LIU Annan, JIANG Zhimei. Research progress in screening tools for autism spectrum disorder at different ages [J]. Chinese Journal of Child Health Care, 2023, 31(6): 645-649.
[8]	LI Menghan, LI Tingyu. Progress in sensory abnormalities in children with autism spectrum disorder [J]. Chinese Journal of Child Health Care, 2023, 31(6): 650-655.
[9]	JIANG Yanlin, ZHANG Qiang, ZHAI Rui, PENG Yaqi, TAI Ran, WANG Junhong. Systematic review of the prevalence and risk factors of tic disorders in Chinese children [J]. Chinese Journal of Child Health Care, 2023, 31(6): 661-667.
[10]	LIU Mengjiao, ZHENG Xiaoqin, MENG Xian, WU Xiaoling, GE Dongmei, NIE Jing. Intelligence characteristics of 2- to 5-year-old children with autism spectrum disorder, suspected autism spectrum disorder and global developmental delay [J]. Chinese Journal of Child Health Care, 2023, 31(6): 668-673.
[11]	. [J]. Chinese Journal of Child Health Care, 2023, 31(6): 693-696.
[12]	LI Jia, ZHANG Yanchi. Research advances on the correlation of gene polymorphisms of vitamin D receptor and vitamin D level with neurodevelopmental disorders in children [J]. Chinese Journal of Child Health Care, 2023, 31(5): 516-520.
[13]	LIU Jiamin, ZHAO Sha, ZHONG Yan. Research advance on exosomes and neuropsychiatric disorders in children [J]. Chinese Journal of Child Health Care, 2023, 31(5): 521-525.
[14]	ZENG Hongling, ZHOU Yi, XIE Jun, DAI Lisha, TANG Jun. Effect of group training based on the treatment and education of autistic and communication handicapped children on preschool children with autism spectrum disorder [J]. Chinese Journal of Child Health Care, 2023, 31(5): 564-569.
[15]	ZHANG Jie, AN Yingping, YANG Yi, ZHANG Yannan, TIAN Lin. Interpretation of "Females with ADHD:An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women (2020) " [J]. Chinese Journal of Child Health Care, 2023, 31(5): 570-575.